207_Combined course Presentations

Overall Survival

40

35

M e d i

M e d i a n

35

30

30

25

a n

25

20

20

S u r v i v a l

15

S u r v i v a l

15

10

10

5

5

0

0

bradley 2010 cho 2009

gavila 379

choy 2000

videtic 765

ready 2010

saha pg497

chang 2011

kaplan 2004

nyman 2009

giorgio 2007

KONG haken

vokes 2007-1

socincki 2008

belani 2005-1

lawrence 2013-2 Hoang 2012-1

takayama 2013

el-hadaad 2013

rosenman 2002

schuette 2012-1

carter 2012-total

p=0.35

blumenschein 2011

bradley rt0g 0617-1

stinchcombe 2008 NOV

Study

Study

Cisplatin/Etoposide Weighted median survival = 19.4 months (N=2770)

Carboplatin/Paclitaxel Weighted median survival = 18.4 months (N=3602)

Steuer CE. et al. JAMA 2016;4280